Detailed disclosure is attached.

7 August 2026 BSE Limited (Security Code: 524314) Phiroze Jeejeeboy Towers, Dalal Street, Fort, Mumbai- 400 001. Dear Sirs, Sub: Outcome of the Board Meeting held on 7 August 2026 – Unaudited Standalone Financial Results of the Company for the first quarter ended 30 June 2026 - Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Ref: Intimation of Board Meeting vide letter dated 1 August 2026 We hereby inform you that, in compliance with Regulation 30 read with Schedule III, Regulation 33 and other applicable provisions of the SEBI Listing Regulations, the Board of Directors of Gujarat Terce Laboratories Limited (“the Company”), at their Meeting held today viz. Friday, 7 August 2026, has inter-alia, approved Unaudited Standalone Financial Results of the Company for the first quarter ended 30 June 2026, subjected to Limited Review of the Statutory Auditor of the Company. In this regard, please find enclosed the following documents prepared in compliance with Regulations 33 and 47 (as applicable) of the SEBI Listing Regulations: 1. Unaudited Standalone Financial Results for the first quarter ended 30 June 2026, and notes thereon; 2. Unmodified Limited Review Report on the Unaudited Standalone Financial Results for the first quarter ended 30 June 2026, issued by the Company’s Statutory Auditor – Shah Doshi Patel & Associates LLP; The Meeting of the Board of Directors of the Company commenced at 3:00 p.m. (IST) and concluded at 4:30 p.m. (IST). This intimation is also being uploaded on the website of the Company and can be accessed at the weblink: https://www.gujaratterce.in/financial-results/ Thanking you For Gujarat Terce Laboratories Limited Ms. Ashka Solanki Company Secretary Enclosures: As above